Central Giant Cell Granuloma (CGCG) is a benign but potentially aggressive lesion that typically occurs in the jawbones, particularly in the mandible and maxilla. It is characterized by the presence of giant cells, which are large cells formed by the fusion of macrophages. CGCG can cause significant bone destruction and deformity, especially if it is aggressive in nature. The exact cause of CGCG remains unknown, but it is more commonly seen in children and young adults.
Symptoms
Common signs of Central Giant Cell Granuloma include:
• Swelling or a noticeable mass in the jaw area
• Pain or discomfort in the affected region
• Tooth displacement or mobility
• Numbness or tingling in nearby areas
• Rapid growth of the lesion in aggressive cases
• Swelling or a noticeable mass in the jaw area
• Pain or discomfort in the affected region
• Tooth displacement or mobility
• Numbness or tingling in nearby areas
• Rapid growth of the lesion in aggressive cases
Causes
The exact causes of CGCG are not well understood, but potential factors may include:
• Genetic predispositions
• Previous trauma to the jaw
• Hormonal influences, as it often appears in younger individuals
• Genetic predispositions
• Previous trauma to the jaw
• Hormonal influences, as it often appears in younger individuals
Diagnosis
Diagnosing CGCG typically involves:
• Physical Examination: Assessment of symptoms and visual inspection of the lesion.
• Imaging Tests: X-rays, CT scans, or MRIs to determine the size and extent of the lesion.
• Biopsy: A small sample of tissue may be taken for histopathological analysis to confirm the diagnosis.
• Physical Examination: Assessment of symptoms and visual inspection of the lesion.
• Imaging Tests: X-rays, CT scans, or MRIs to determine the size and extent of the lesion.
• Biopsy: A small sample of tissue may be taken for histopathological analysis to confirm the diagnosis.
Treatment Options
Treatment for Central Giant Cell Granuloma varies depending on whether the lesion is aggressive or non-aggressive. Options include:
• Surgical Approaches:
• Curettage: Removal of the lesion using a curette, often with good outcomes for smaller lesions.
• Resection: More extensive surgeries like segmental mandibulectomy or maxillectomy may be necessary for larger or aggressive lesions.
• Non-Surgical Treatments:
• Intralesional Corticosteroids: Injections that can reduce lesion size and are often used before surgery.
• Calcitonin Therapy: Administered via injections or nasal sprays to inhibit bone resorption.
• Denosumab: A monoclonal antibody that targets RANK/RANKL pathways, showing promise in managing aggressive cases.
• Surgical Approaches:
• Curettage: Removal of the lesion using a curette, often with good outcomes for smaller lesions.
• Resection: More extensive surgeries like segmental mandibulectomy or maxillectomy may be necessary for larger or aggressive lesions.
• Non-Surgical Treatments:
• Intralesional Corticosteroids: Injections that can reduce lesion size and are often used before surgery.
• Calcitonin Therapy: Administered via injections or nasal sprays to inhibit bone resorption.
• Denosumab: A monoclonal antibody that targets RANK/RANKL pathways, showing promise in managing aggressive cases.
Frequently Asked Questions
Q: What are the risks if CGCG is left untreated?
A: Untreated CGCG can lead to significant bone loss, deformity, and complications such as tooth displacement.
Q: How long does recovery take after surgery?
A: Recovery time varies but generally ranges from a few weeks to several months depending on the extent of surgery
Q: Can CGCG recur after treatment?
A: Yes, there is a possibility of recurrence, particularly with aggressive forms; regular follow-up appointments are essential.
Contact
Please feel free to contact us with any general or medical enquiry by calling us.
